Institute of Bioorganic Chemistry
http://iboch.bas-net.by/
220141 Minsk, Academician Kuprevich ST, 5/2
http://iboch.bas-net.by/
220141 Minsk, Academician Kuprevich ST, 5/2
An original technology and a test system created on its basis for the early diagnosis of pancreatitis
COUNTRY OF ORIGIN
BelarusIDENTIFIER
BO3910PUBLISHED
2021-05-21LAST UPDATE
2021-05-21DEADLINE
Linked profile in other language
Responsible
Aleksej Yantsevich
+375 17 357 8761
info@iboch.by
+375 17 357 8761
info@iboch.by
Summary
The Institute of Bioorganic Chemistry offers consumers a test system for early diagnosis of pancreatitis under a manufacturing agreement and is looking for partners to sell technology for obtaining test systems to conclude a license agreement and a distribution service agreement.
Description
A set of reagents "FLA2-FOA" for determining the activity of pancreatic phospholipase A2 in human blood by the method of photometric analysis.
An original technology has been developed that allows, based on the results of preclinical and clinical trials, the use of a test system for determining the activity of PLA2 developed on its basis, which is implemented using the created set of reagents "FLA2-FOA", in clinical and laboratory practice in the process of differential diagnosis of severe forms of necrotizing pancreatitis as an informative laboratory biochemical test.
An original technology has been developed that allows, based on the results of preclinical and clinical trials, the use of a test system for determining the activity of PLA2 developed on its basis, which is implemented using the created set of reagents "FLA2-FOA", in clinical and laboratory practice in the process of differential diagnosis of severe forms of necrotizing pancreatitis as an informative laboratory biochemical test.
Advantages and Innovations
Registration certificate for industrial production IM-7.103513 dated 30.11.2015.
Stage of development
Already on the market
Comments regarding stage of development
Production is organized jointly with a unitary enterprise
"Self-supporting pilot production of the Institute of Bioorganic Chemistry
NAS of Belarus ".
"Self-supporting pilot production of the Institute of Bioorganic Chemistry
NAS of Belarus ".
Funding source
State budged
Internal
Internal
IPR status
Exclusive rights
Patents granted
Secret know-how
Patents granted
Secret know-how
Comments regarding IPS status
Patents of the Republic of Belarus: No. 12552 "Method for determining the activity of phospholipase A2 in blood serum", No. 13143 "Method for diagnosing pancreatitis by level A2 of phospholipase activity in blood serum".
Sector group
BioChemTech
Healthcare
Healthcare
Client information
Type
R&D institution
Year established
1974
NACE keywords
A.01.61 - Support activities for crop production
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Already engaged in transnational cooperation
Yes
Additional comments
A significant amount of fundamental research is carried out under grants from the Belarusian Republican Foundation for Basic Research, including with the participation of international partners - organizations from Russia, the Czech Republic, etc.
Languages spoken
English
Russian
Russian
Information about partnership
Type of partnership considered
Distribution services agreement
License agreement
Manufacturing agreement
License agreement
Manufacturing agreement
Type and role of partner sought
Consumer test system for early diagnosis of pancreatitis as part of a manufacturing agreement.
Partners for the sale of technology for obtaining test systems for early diagnosis of pancreatitis under a license agreement and a distribution service agreement.
Partners for the sale of technology for obtaining test systems for early diagnosis of pancreatitis under a license agreement and a distribution service agreement.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
Attachments
Количество уникальных просмотров в одной сессии: 2050
Статистика ведется с 22.05.2021 14:16:41
Статистика ведется с 22.05.2021 14:16:41